Topline data were announced from two phase 3 trials evaluating deucravacitinib in adults with active psoriatic arthritis.

Patients with rheumatoid arthritis who demonstrate consistent long-term elevation of inflammatory markers have an increased ...

Emerging evidence supports the argument that psoriatic arthritis arises from two pathways and that affected immune cells may ...

Discover how both heat and cold can impact psoriatic arthritis symptoms and learn which is best for your relief.